Physician profile
Ryan Flug
NPI 1003299702
$1,157.18
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $909 · 2022: $183 · 2023: $65.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $65.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $65.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $240.47 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $144.17 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $135.36 | 2021-2022 | |
| Astellas Pharma US INC | $112.75 | 2021 | |
| Lilly USA, LLC | $111.60 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.93 | 2021-2023 | Jardiance |
| Nestle Healthcare Nutrition INC. | $83.43 | 2021 | |
| Novo Nordisk INC | $43.75 | 2021 | |
| Sanofi-Aventis U.S. LLC | $40.10 | 2021 | |
| Abbott Laboratories | $38.25 | 2021 | |
| Amgen INC. | $35.71 | 2021 | |
| Mylan Specialty L.P. | $17.76 | 2021 | |
| Janssen Pharmaceuticals, INC | $16.19 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.45 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.38 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Flug listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.